Cover Image
QR Code

MiR-936 Targets GPR78 and Regulates Chemotherapy Resistance in Non-Small Cell Lung Cancer by Activating the Galphaq Rho GTPase Pathway.

Published in:Alternative Therapies in Health & Medicine Vol. 29; no. 2; pp. 58 - 64
Main Authors: Xiuming Huang, Yanyan Wang, Minbiao Chen, Gao Li
Format: Journal Article
Published: InnoVisions Professional Media Mar2023
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163438554&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163438554
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10786791
        88C
      jtl: Alternative Therapies in Health & Medicine
      issn: 10786791
      maglogo: N
    pubinfo:
      dt: Mar2023
      vid: 29
      iid: 2
      pid: 65582
      pub: InnoVisions Professional Media
      place: Eagan, Minnesota
    artinfo:
      ui:
        163438554
        163438554
      ppf: 58
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: MiR-936 Targets GPR78 and Regulates Chemotherapy Resistance in Non-Small Cell Lung Cancer by Activating the Galphaq Rho GTPase Pathway.
      aug:
        au:
          Xiuming Huang
          Yanyan Wang
          Minbiao Chen
          Gao Li
        affil: Department of Thoracic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N